Biomarkers and immune-modulating therapies for type 2 diabetes.

  title={Biomarkers and immune-modulating therapies for type 2 diabetes.},
  author={Barbara M. Brooks-Worrell and Radhika R Narla and Jerry P. Palmer},
  journal={Trends in immunology},
  volume={33 11},
Recent advances in understanding the etiology of obesity, metabolic syndrome, and type 2 diabetes (T2D) have established involvement of the immune system. These developments highlight the potential of immunomodulatory therapies for treatment of these conditions. Here, we discuss current and new immunotherapeutic strategies for the treatment of T2D, the need… CONTINUE READING